SynthesisFrontiers in endocrinology2022

Sodium Glucose Cotransporter Type 2 Inhibitors Improve Cardiorenal Outcome of Patients With Coronary Artery Disease: A Meta-Analysis.

Wen Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.